fda approval semaglutide mash Wegovy (semaglutide 2.4 mg) approved in the US for the treatment of - Novo Nordisk fda semaglutide mash Approval Expands

Each pen delivers 4 doses of the 1 mg strength and will last for one month

Compounded NAD+ NAD+ $245/month Quality you can trust VitalMeds sources medications from state-licensed pharmacies and ensures rigorous third-party testing for safety, purity, and effectiveness

This guide breaks down the pharmacology, the mechanistic contrast, the head-to-head trial evidence (including the 2025 SURMOUNT-5 results), what enthusiast and research communities online are saying, and the practical realities of sourcing both compounds in Canada

Cloudiness or particles mean the medication is compromised

Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide is a dual agonist it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously